期刊论文详细信息
Trials | |
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial | |
Rachel Phillips1  Victoria Cornelius1  Melanie Almonte2  Dragana Milojkovic2  Taryn Youngstein2  Mark Thursz2  Asad Charania2  Onn Min Kon2  Lucy Cook2  Tina Shturova2  Graham Cooke2  Nikhil Vergis2  Clio Pilay2  Andew J. Innes2  Alexia Katsarou2  Richard Turner2  Nichola Cooper2  Michelle Willicombe2  Svetlana Cherlin3  James Wason3  | |
[1] Imperial Clinical Trials Unit and Imperial College, London, UK;Imperial College, London and Imperial NHS Trust, London, UK;Newcastle Clinical Trials Unit and Newcastle University, Newcastle upon Tyne, UK; | |
关键词: COVID-19; coronavirus; randomised controlled trial; protocol; pneumonia; fostamatinib; ruxolitinib; | |
DOI : 10.1186/s13063-021-05190-z | |
来源: Springer | |